Abstract. The diagnosis value of polymerase chain reaction (PCR) was assessed in patients from an area endemic for American cutaneous leishmaniasis (ACL) in Brazil. Different forms of clinical sample preservation and DNA extraction for PCR were tested. The 4 preservation forms of the skin biopsies from patients suspected to have ACL were as follows: imprinted on filter paper (FP); imprinted on nitrocellulose paper (NP); frozen at Ϫ20ЊC (FB); or immersed in 70% ethanol (EB). The DNA was extracted by elution from FP and NP and by enzyme digestion from FB and EB. Clinical examinations and parasitological or immunological tests confirmed the cases of ACL. Of 164 patients suspected to have ACL, 133 patients (81.1%) were confirmed. The PCR was positive in 76.8% of the suspected cases and in 90.2% of the confirmed cases. Polymerase chain reaction alone showed nearly the same positivity of the parasitological and immunological tests together; positivity varied 73.3-82.2%, according to the means by which the samples were preserved or the way the DNA was extracted. This variation was not significantly different (P Ͼ 0.05). Therefore, we recommend that clinical samples from patients with ACL should be collected and preserved on FP and the DNA further extracted by elution. The samples can be mailed to reference laboratories for the definitive diagnosis of ACL. This alternative is simple, inexpensive, and adequate for field conditions in developing countries.
INTRODUCTION
American cutaneous leishmaniasis (ACL) is a zoonotic disease that infects humans and wild and domestic animals. The causative agents are protozoa belonging to the Kinetoplastidae order and Leishmania genus. In the New World, the major species involved in human infections are taxonomically grouped in the subgenus Viannia and Leishmania. 1 The vectors responsible for the transmission are phlebotomine sand flies (Diptera: Lutzomyia). The genetic characteristics and immune response of the host associated with Leishmania species determine the course of infection in animals and humans. 2, 3 Leishmaniasis is one of the greatest public health problems in some developing countries. It affects populations in Ͼ 80 countries worldwide. The number of people exposed to the risk of acquiring this disease was estimated at 350 million and the infected people at ϳ 12 million. 4 Leishmaniasis are found in Americas from the south of the United States to the north of Argentina. In Brazil, from 1987 to 1996, ϳ 28,000 new leishmaniasis cases were recorded each year. 5 No single technique has stood out as the gold standard for diagnosing Leishmania infection. More than one method has been applied in laboratories for both the parasite and antibody findings. 3, 6 Although simple and rapid, the search for parasites via microscopy in samples taken from lesions has a low sensitivity. 6, 7 Culture techniques to isolate the parasite may yield greater sensitivity; 7 however, they have limitations related to cost, contamination, and delay in obtaining the results. Humoral immune tests are considered limited for ACL diagnosis due the low reactivity rates present in patients with simple lesions of the cutaneous form, which are the most frequent, and the high cross-reactivity with other infections. 8 The Montenegro skin test (MST) has a 90% positivity in diagnosing ACL cases 9 and evaluating the cellular immune response, so this is the most frequently used technique in the laboratory.
Over the last 10 years, polymerase chain reaction (PCR) has been extensively used for the ACL diagnosis by means of searching for Leishmania DNA in human lesions and animal reservoirs that are suspected to harbor ACL infection. [10] [11] [12] [13] [14] Sensitivity of PCR was found to be greater when primers were targeted to the Leishmania kinetoplastic DNA (kDNA) minicircles. 10 Despite its several technical advantages, the costbenefit ratio in routine diagnosis and distance between endemic areas and specialized laboratories are still inconvenient. Therefore, we decided to simplify clinical sample collection so that samples could be mailed from the field to specialized laboratories, reducing the distance between them.
Here, we reassess the diagnosis of ACL by means of PCR using different forms of clinical sample preservation and DNA extraction as Leishmania DNA sources. We have also compared the ACL diagnosis by PCR with the diagnosis by microscopic findings of the parasite and by MST.
MATERIALS AND METHODS
Selection of the patients. In 1997-2000, a total of 164 patients with cutaneous lesions who were suspected to have ACL were examined at the Leishmaniasis out-patient clinic, a reference medical service for cutaneous leishmaniasis, located in the city of Caratinga, Minas Gerais state, Brazil. The patients were from rural regions of Vale do Rio Doce, an area endemic for ACL. In initial clinical observations, clinicians performed differential diagnoses related to other kinds of cutaneous lesions, such as varicose ulcer, blastomycosis, and sporotrichosis. Patients who presented with typical cutaneous ulcers with positive parasitological or MST tests were defined as an ACL clinical case and were considered for inclusion in the study; 15 these patients received antimonial therapy. 16 Glucantime-Rhodia (N-methylglucamine) was used at a dose of 17 mg Sb v per kilogram of body weight per day, administered intramuscularly, during 10 days. The dose was repeated after a 10-day interval until the lesions were healed. For some patients, chemotherapy plus immunotherapy was used. 17 Informed consent was obtained from all patients. The project was approved by the Ethical Committee for Human Research of the Santa Casa de Misericórdia Hospital of Belo Horizonte, Minas Gerais state, Brazil (no. 007/98).
Microscopic examination and MST. After ulcer asepsis, 0.5-1.0 mL of 2% Xylocaine was subcutaneously injected nearby. With a scalpel fitted with a disposable blade, we performed a skin biopsy for each patient, taking a small, wedge-shaped fragment of the tissue (5 mm in length) from the border of the ulcerated lesion. After removing the extra blood from the biopsy fragment, 12 imprints were performed with absorbent paper for each of 3 microscopic slides. After air drying, slides were fixed in methanol, stained with Giemsa, and observed via optical microscopy for the amastigote form of the parasite; the results were given after a thorough examination of 3 slides.
The MST assessed the cellular immune response of the patient with ACL. A promastigote antigen was used from resuspended Leishmania amazonensis (clone PH8-1 IIId), which was suspended in saline solution containing 1:10,000 merthiolate and sonicated. 18 This antigen was produced by Biobrás S.A. (Montes Claros MG, Brazil) under good manufacturing practice conditions (registered as Montenegro antigen C-40). Production and performance conditions of the test have been described elsewhere. 19 The MST was considered positive when 48 hr after injection, nodules Ն 5 mm in diameter were observed.
Clinical sample preservation and parasite DNA extraction. The same biopsy fragment used in the direct microscopic examination was washed in phosphate-buffered saline and imprinted on filter paper (FP) and on nitrocellulose paper (NP). The fragment was further sectioned in halves, with half preserved in 70% ethanol (EB) and the other half frozen at Ϫ20ЊC (FB).
For DNA extraction from the FP-and NP-imprinted biopsies, 7-mm paper circles were cut out, added to 50 L Milli-Q water, and boiled for 10 min. After centrifugation at 14,000 ϫ g for 5 min at room temperature, the supernatant was used as Leishmania DNA source for the PCR reaction. 20 The extraction of DNA from EB and FB samples was performed with 100 L buffer solution (10 mM Tris-HCl and 1 mM ethylenediamine tetraacetic acid [EDTA], pH 8.0) and 100 g/mL proteinase K (final concentration), left at 56ЊC for 3 hr, and homogenized from time to time. After proteinase K inactivation by boiling for 15 min, the digested samples were centrifuged, and the supernatant was used as the Leishmania template DNA source for the PCR reaction. 21, 22 To avoid bias, the study was conducted in a blind fashion, without knowledge of the status of the samples.
The DNA standards were obtained from Leishmania reference strains MHOM/BR/1975/M2903 and MCAN/BR/ 1973/BH348 23 (L. braziliensis) from a cryobank at the Laboratório de Leishmanioses, Departamento de Parasitologia (Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais). The Leishmania standard DNAs were obtained from promastigote forms from reference strains cultivated in liver infusion tryptose medium and collected at the exponential growth phase. Cultures were washed 3 times in sterile phosphate-buffered saline solution, pH 7.2, at 4ЊC and centrifuged at 500 ϫ g for 15 min. We extracted DNA as described previously. 21 To exclude the possibility of crossreactions, we used 26 samples of skin fragment biopsies from patients without skin lesions or from patients with dermal lesions other than ACL.
Polymerase chain reaction. The primers directed to amplify the conserved region of the Leishmania kDNA minicircle were as follows 24, 25 : forward: 5Ј-GGG (G/T)AG GGG CGT TCT (G/C)CG AA-3Ј; reverse: 5Ј-(G/C)(G/C)(G/C) (A/T)CT AT(A/T) TTA CAC CAA CCC C-3Ј. Reaction mixtures contained 200 M each of dUTP, dATP, dCTP, and dGTP, 1 M of each primer, buffer (10 mM Tris-HCl, 50 mM KCl, pH 8.0), 1.5 mM MgCl 2 , 0.75 U of Taq DNA polymerase (PhN, Belo Horizonte, Minas Gerais State, Brazil) and 1 L of DNA sample in a final volume of 10 L. Twenty microliters of mineral oil was poured over the reaction mixture to avoid evaporation. The PCR conditions were as follows: initial denaturation at 94ЊC for 5 min, followed by 29 cycles at 94ЊC for 1 min, 60ЊC for 1 min, 72ЊC for 30 sec, and a final extension at 72ЊC for 5 min. Negative and positive PCR controls were included in each reaction set. The negative control contained no DNA, and the positive control contained 0.01 and 1.0 pg of standard Leishmania DNA.
After amplification, 3 L of the product was resuspended in an equivalent volume of buffer sample 2ϫ (0.25% bromophenol blue, 0.25% xylene cyanol, and 15% Ficoll). Electrophoresis was performed in 8% polyacrylamide gel at 40 mA in 89 mM Tris, base pH 8.0, 89 mM boric acid, and 2 mM EDTA in a mini-gel system (Bio-Rad Laboratories, Hercules, CA). The DNA molecular size markers of the bacteriophage X 174 digested by HaeIII (Pharmacia, San Francisco, CA) was used. Afterward, the gels were stained with 0.2% silver. 26 To assess possible PCR failures in detecting Leishmania DNA, an inhibition test was performed with the samples that showed PCR-negative results. It was performed in the same PCR tube in which the negative sample, 10 fg of standard Leishmania DNA (v/v), was added. The positive result meant absence of inhibition. Stability tests were undertaken to assess the preservation of DNA extracted by elution and enzyme digestion. The DNA preparations were stored at 4ЊC and after 6 and 12 months, PCR was performed.
Data analysis. Comparative analysis of the PCR positivity in relation to the MST and the microscopic examinations, as well as positivity assessment of the 4 forms of clinical samples preservation and the 2 DNA extraction procedures, were carried out by the chi-square test.
RESULTS

Diagnosis of ACL by parasitological and MST tests.
The positivity of the parasitological and MST tests is shown in Table 1 . Each test alone showed nearly the same positivity for both patients with suspected ACL or patients with confirmed ACL. Together, the 2 tests increased ACL positivity to 81.1% of the suspected patients. All 133 ACL-confirmed patients were treated and cured.
Results of PCR. Figure 1 is a representative panel of the results of PCR amplification on a group of patients. A unique The statistical analysis showed that there is an evident association between PCR results and the parasitological and MST tests together (P ϭ 0.000). The PCR positivity decreased as either one or both tests became negative. The PCR was positive in 6 (19.4%) of 31 patients negative by both the parasitological and the MST tests. Three out of these 6 PCR-positive patients returned to the Leishmaniasis out-patient clinic and repeated the routine diagnosis, and they were confirmed as having ACL. They were then treated and cured.
Positivity of PCR according to the different forms of clinical sample preservation and DNA extraction. Table 3 shows the results of the PCR positivity for each of the 4 forms of sample preservation and the 2 forms of DNA extraction from biological samples of the 90 patients suspected to have ACL. The PCR positivity varied 73.3-78.9%, according to either the form in which the samples were preserved or the DNA that was extracted. This difference was not statistically significant (P ϭ 0.833). The DNA extraction either by elution of FP ϩ NP or by enzyme digestion of EB ϩ FB showed a PCR positivity of 78.9 and 82.2%, respectively. These results were not significant (P ϭ 0.572). The DNA extracted by both procedures and stored at 4ЊC for up to 1 year showed the same PCR positivity. Altogether, the PCR positivity varied 73.3-82.2%, according to the form in which the samples were preserved or the DNA that was extracted (Table 3 ). This variation was not significantly different (P ϭ 0.813).
DISCUSSION
When we compared the routine methods for ACL diagnosis, we verified that the parasitological results found via microscopy showed higher positivity (77.4%) than did the results described in the literature (33.0-63.0%). 11, 13, 14, 27 Several factors might contribute to this high positivity. Among them is the early search by patients with ACL for the health care services of the Leishmaniasis out-patient clinic in Caratinga MG. Such a quest is due to the awareness of the facility in the region, which since 1965 has received Ͼ 6,500 patients. Another reason might be related to the biopsy collections or the making of the slides. Slide imprinting with materials from punch biopsy [11] [12] [13] and lesion scrapings 21 may not be as sensitive as the wedge biopsy specimens used in this study. Furthermore, the thorough microscopic examination of 12 imprints on each slide and 3 slides per patient we performed obviously increased the chances that we would find parasites.
The result of MST positivity was 75.2% for ACL-confirmed patients. The MST, routinely used for ACL immunodiagnosis, has 90% of positivity in ACL cases and is simple to perform. Nevertheless, it is not able to distinguish active from inactive infection. 28 In the present study, we associated the parasitological to the immunological tests to confirm ACL diagnosis. Together, these tests confirmed ACL in 81.1% of the patients suspected to have ACL.
Although there is not a single method that can be used as the gold standard for ACL diagnosis, the results described in the literature for the validation of the PCR are significant. It reached 100.0% sensitivity and specificity compared with direct microscopy. 21 The PCR positivity was 96.9% in patients with ACL who had cutaneous lesions, whereas the conventional methods showed 67.4% positivity for parasite detection. 14 Our results showed a PCR positivity of 90.2% for the ACL-confirmed patients. To evaluate the value of PCR in the diagnosis of ACL, the patients were divided into 4 groups, according to the results of the parasitological and immunological tests. The PCR positivity reached 100% when both parasitological and MST tests were positive and decreased as either one or both tests became negative.
In the group of patients positive by MST alone, PCR showed 60.0% positivity. The PCR test is based on the parasite DNA detection, whereas MST is an indirect method that assesses the cellular immune response. The PCR might be detecting only the current infection, whereas the MST was also detecting past infections. The lowest PCR positivity (19.4%) was reached when the parasitological and MST tests failed to detect ACL. The patients were confirmed to have ACL when they made another trip to the clinic and were cured after treatment. As found by other researchers, 12 we can also conclude that neither the parasitological test nor the MST test alone are accurate enough for ACL diagnosis. Therefore, we suggest the use of PCR as an auxiliary tool for ACL diagnosis in suspected cases of ACL when one or both of the other tests prove negative.
To simplify the protocol, we used crude instead of purified DNA preparation as source of the template for PCR. It is well known that the crude DNA preparation may contain PCR inhibitors. 11, 21, 27, 29 We checked all our PCR-negative results and found that none of them were negative as a result of the presence of inhibitors. Therefore, we reduced the possibility of having false-negative results. Care was also taken to avoid false-positive PCR results as a result of contamination. Both these measures increased the reliability of our PCR results.
The high positivity and short time to obtain results are the main benefits of PCR for diagnosis of ACL. However, the PCR cost-benefit ratio, the need for a somewhat sophisticated laboratory, and the distance between the endemic areas and the reference laboratories remain problems. Thus, we decided to address the simplification of the collection, preservation, and DNA extraction of clinical samples from patients with ACL. Previous studies on visceral leishmaniasis showed the feasibility of the use of FP and NP for collection and preservation of clinical samples. 30, 31 Another work showed a simplified extraction of Trypanosoma cruzi and T. rangeli DNAs in triatomine feces laid on FP. 20 In our study, we used such protocols in clinical samples from patients with ACL. The differences in the PCR positivity of the several procedures of preservation and extraction were not statistically significant. These results confirmed the viability of working with a simplified methodology of collection, preservation, and DNA extraction of clinical samples from patients with ACL.
We recommend that the clinical samples from patients with ACL should be collected and preserved in FP and the DNA further extracted by elution. This alternative is simple, inexpensive, and adequate for field conditions in developing countries. Furthermore, the samples can be mailed to the reference laboratories for the definitive diagnosis of ACL through PCR. Above all, this practice would provide ways to detect ACL that are currently not available in the regions where patients are affected by the disease.
